Refractory Epilepsy Active Not Recruiting Phase 4 Trials for Clobazam (DB00349)

IndicationStatusPhase
DBCOND0032649 (Refractory Epilepsy)Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01932502Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory EpilepsyTreatment